March 23, 2009Consumer Directed Questions and Answers about FDA’s Initiative Against Contaminated Weight Loss Products Consumer Directed Questions and Answers about FDA’s Initiative Against Contaminated Weight Loss Products
Consumer Directed Questions and Answers about FDA’s Initiative Against Contaminated Weight Loss Products (updated) Source: www.fda.gov FDA issues Information for Healthcare Professionals for Zonisamide FDA issues Information for Healthcare Professionals for Zonisamide Source: www.fda.gov FDA Takes New Regulatory Action Against Ranbaxy’s Paonta Sahib Plant in India FDA Takes New Regulatory Action Against Ranbaxy’s Paonta Sahib Plant in India Source: www.fda.gov Guidance for Industry Newly Added Bioequivalence Recommendations Source: www.fda.gov Transdermal Drug Patches with Metallic Backings: Risk of Burns during MRI Scans Public Health Advisory issued describing risk of skin burns during MRI scans. Source: www.fda.gov Zencore Plus Nationwide recall of supplement, found to contain an undeclared drug, which may cause life-threatening risk of sudden drop in blood pressure. Source: www.fda.gov Drug Safety Oversight Board Meetings Memorandum of Meeting Minutes, Drug Safety Oversight Board Meeting, January 15, 2009 Source: www.fda.gov Colleague Single and Triple Channel Volumetric Infusion Pumps by Baxter Class 1 Recall issued because software and battery usage failures were identified that result in a delay in or interruption of infusion that may cause serious injury and/or death. Source: www.fda.gov Meeting/Forum Drug Information Association (DIA): Cardiovascular Safety, QT, and Arrhythmia Assessment in Drug Development, April 29-May 1, 2009, Hyatt Regency Besthesda, Bethesda, MD. Meeting information Source: www.diahome.org # posted by Network @ 12:50 AM
 |
Subscribe to Posts [Atom]